Page last updated: 2024-08-25

magnolol and bakuchiol

magnolol has been researched along with bakuchiol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Yang, SP; Yue, JM	1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1

Other Studies

2 other study(ies) available for magnolol and bakuchiol

Article	Year
Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi. Bioorganic & medicinal chemistry letters, 2001, Dec-17, Volume: 11, Issue:24 Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Trees; Triterpenes	2001
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012

Article

Year

Two novel cytotoxic and antimicrobial triterpenoids from Pseudolarix kaempferi.

Bioorganic & medicinal chemistry letters, 2001, Dec-17, Volume: 11, Issue:24

Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Trees; Triterpenes

2001

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012